# Stage 62 — Draft Author Review Feedback and Audit Integrity

## Objective
Give the **creator** of a staged six-class catalog configuration bundle a safe, read-only view of the **current unsigned signatory-policy draft revision's** independent clinical and financial procedural comments. Superseded reviews must remain in append-only audit history but must not be represented as current or approved.

## Delivered
- `src/lib/catalog-policy-feedback.ts`: deterministic, revision-bound AuditEvent review summary for two distinct actors and two distinct clinical/finance domains, rejecting >2 reviews, malformed flags, forged revision/digest, author self-review, repeated reviewers or repeated domains.
- `src/app/api/catalog/imports/[id]/bundle-drift/route.ts`: loads only current-draft AuditEvent IDs **inside existing author-only, full-batch live-source/branch/department/price authorization transaction**, under active organization row lock. A newly recorded revision immediately resets its feedback to PENDING. Invalid current-revision evidence yields HTTP 409 instead of partial/incorrect summaries.
- `src/components/catalog-governance-readiness.tsx`: bilingual AR/EN feedback summary with separately visible clinical/financial status, reason and revision. Explicit NOT approval. On a new revision the UI shows fresh pending states, not inherited reviews.
- `tests/stage-62-policy-author-feedback.test.ts`: no authorization, draft-integrity, duplicate/reviewer-separation, stale-revision/source/UI guards.
- `tests/stage-62-policy-author-feedback-mariadb.integration.test.ts`: two real database connections, current/previous revision observations, independent reviewer audit records, tenant isolation, spoofed self-review rejection, no clinical-master mutation.
- `.github/workflows/ci.yml`: dedicated Stage 62 MariaDB test, previous tests retained.

## Release and safety limits
- No schema migration and no mutation to active catalog prices, units, medical reference ranges, patient clinical history or invoices.
- `UNAPPROVED_DRAFT` and `PROCEDURAL_REVIEW_ONLY` remain NONBINDING: neither `NOTED_FOR_DISCUSSION` nor `RETURN_FOR_REVISION` creates medical/financial approval, electronic signature, price publication or reference interval activation. Flags stay `reviewOnly=true`, `approved=false`, `signingEnabled=false`, `activated=false`, `liveWrites=false`.
- Does not expose reviewer identity, clinical/financial source values or raw audit blobs. The author already needs present, intersected tenant/branch/department and live domain grants and full-batch scoped reconciliation.
- SHA256 proposal checksum is **not** a legally authenticated signature. A forged DB audit record cannot be ruled out cryptographically from its digest alone; structural corruption and replay across revisions are rejected.
- Clinical sign-off policy, legally trusted electronic signers, MFA re-auth at signing, effective-dated application, and final clinical and financial authorization require separately approved governance and remain disabled.
- Automated tests and CI provide engineering evidence; physical analyzers, full operational UAT, clinician/cashier validation, and Hostinger deployment confirmation remain deferred to their respective release gates.
